pentaerythritol has been researched along with Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, KK; Geary, SM; Salem, AK | 1 |
Chen, W; Cheng, R; Deng, C; Feijen, J; Meng, F; Zhong, P; Zhong, Z | 1 |
2 other study(ies) available for pentaerythritol and Neoplasms
Article | Year |
---|---|
Development and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine.
Topics: Adjuvants, Immunologic; Animals; Antigens; Biocompatible Materials; Cancer Vaccines; Chemistry, Pharmaceutical; Cytokines; Dendritic Cells; Female; Lactic Acid; Lipid A; Mice; Mice, Inbred C57BL; Neoplasms; Ovalbumin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Propylene Glycols; Toll-Like Receptors | 2016 |
Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
Topics: Animals; Antibiotics, Antineoplastic; Benzylidene Compounds; Carbonates; Cell Line; Cell Survival; Delayed-Action Preparations; Doxorubicin; HeLa Cells; Humans; Hydrogen-Ion Concentration; Mice; Micelles; Neoplasms; Oxidation-Reduction; Polyethylene Glycols; Propylene Glycols; Succinimides | 2013 |